PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Emerging Infectious Diseases Program, Duke-NUS Medical School, Singapore, Singapore.\', \'Institute of Molecular and Cell Biology (IMCB), A*STAR, Singapore, Singapore.\', \'National Centre of Infectious Diseases, Singapore, Singapore.\', \'Department of Infectious Diseases, Singapore General Hospital, Singapore, Singapore.\', \'Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.\', \'Division of Infectious Disease, University Medicine Cluster, National University Hospital, Singapore, Singapore.\', \'Department of Microbiology and Immunology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.\', \'Emerging Infectious Diseases Program, Duke-NUS Medical School, Singapore, Singapore. antonio@duke-nus.edu.sg.\', \'Singapore Immunology Network, A*STAR, Singapore, Singapore. antonio@duke-nus.edu.sg.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1038/s41586-020-2550-z
?:doi
?:hasPublicationType
?:journal
  • Nature
is ?:pmid of
?:pmid
?:pmid
  • 32668444
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 17.875
?:rankingScore_hIndex
  • 1052
is ?:relation_isRelatedTo_publication of
?:title
  • SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all